Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Low dose valproic acid treatment caused hair loss in a young patient.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Stopping fluvoxamine can reverse hair loss caused by the drug.

Dual anti-seizure medications, especially valproic acid with lamotrigine, often cause more side effects like hair loss and memory issues.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Treatment with benzylpenicillin and prednisolone cured the patient's syphilis and hair loss.

Terazosin and finasteride together cause no major issues.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.